Renaissance Capital LLC Royalty Pharma PLC Transaction History

Renaissance Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$32.77 - $39.4 $444,000 - $533,830	-13,549 Reduced 9.86%	123,913 $4.46 Million
Q4 2022 Jan 06, 2023	SELL	$39.17 - $44.04 $95,104 - $106,929	-2,428 Reduced 1.74%	137,462 $0
Q3 2022 Oct 06, 2022	SELL	$39.88 - $44.65 $1.04 Million - $1.17 Million	-26,150 Reduced 15.75%	139,890 $5.62 Million
Q2 2022 Jul 11, 2022	BUY	$37.53 - $44.22 $2.4 Million - $2.83 Million	63,988 Added 62.7%	166,040 $6.98 Million
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $1.14 Million - $1.3 Million	-30,561 Reduced 23.05%	102,052 $3.98 Million
Q4 2021 Feb 01, 2022	SELL	$35.17 - $42.48 $817,174 - $987,022	-23,235 Reduced 14.91%	132,613 $5.29 Million
Q3 2021 Feb 01, 2022	SELL	$36.14 - $42.24 $8.1 Million - $9.47 Million	-224,213 Reduced 58.99%	155,848 $5.63 Million
Q2 2021 Feb 01, 2022	SELL	$39.85 - $46.63 $2.9 Million - $3.4 Million	-72,887 Reduced 16.09%	380,061 $15.6 Million
Q1 2021 Feb 01, 2022	BUY	$42.34 - $52.82 $10.8 Million - $13.5 Million	256,158 Added 130.17%	452,948 $19.8 Million
Q4 2020 Feb 01, 2022	BUY	$36.12 - $50.05 $7.11 Million - $9.85 Million	196,790 New	196,790 $9.85 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.